Q1 2026 – LC-MS/MS MetID Service
January 21, 2026 6:31 pm Leave your thoughtsQ1 2026 Newsletter – LC/MS-MS MetID Service Hypha provides a high quality LC-MS/MS based MetID Service to complement our existing...
View Article
Q1 2026 Newsletter – LC/MS-MS MetID Service Hypha provides a high quality LC-MS/MS based MetID Service to complement our existing...
View Article
Paper Pick – The role of metabolites in drug-drug interactions Our last paper pick of the year is an excellent...
View Article
Metabolism of 2024 FDA Approved Small Molecules – PART 2 By Julia Shanu-Wilson As we near the end of 2025,...
View Article
Paper Pick – The application of mechanistic absorption, distribution, metabolism and excretion studies and physiologically-based pharmacokinetic modeling in the discovery...
View Article
Launch of New MetID Services Hypha Discovery is excited to announce that we have extended our metabolite identification services to...
View Article
Paper Pick – Intestinal Secretion Is a Potentially Important Clearance Mechanism for Low Metabolic Clearance Compounds In this paper, scientists...
View Article
Biocatalytic paths to the synthesis of selected metabolites of Iptacopan In a recent paper published in celebration of the 20th...
View Article
Small but mighty: the impact of tertiary alcohols in drug design By Julia Shanu-Wilson Creating a drug with perfect drug-like...
View Article
Launch of PolyUGTs Kits Our PolyUGTs screening and scale-up kits are now available! They’re a super easy way to make...
View Article
Oxidative biotransformation of elinzanetant to 3 active metabolites Elinzanetant is a dual neurokinin-1,3 receptor antagonist under development for treatment of...
View Article